Flores, Eduardo P.
HRN: 21-52-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/06/2022
07/14/2022
IVT
500mg
Q8
Fungating Mass R Gluteal Area With Multiple Fistula
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes